Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3063% above fair value
$11.38−0.29 (-2.49%)
Close on Nov 13, 2026Market cap $251.55MP/E –Yield –
Amarin operating margin
Operating margin is operating income as a percentage of revenue.
Amarin's operating margin for the twelve months ending Sep 30, 2026 was -18.2%. For fiscal 2025 it was -23.5%, against -40.2% the year before. The highest annual figure on record is 1.8% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -23.5% | +16.7 |
| FY2024 | Dec 31, 2024 | -40.2% | −18.1 |
| FY2023 | Dec 31, 2023 | -22.0% | +6.7 |
| FY2022 | Dec 31, 2022 | -28.7% | −30.5 |
| FY2021 | Dec 31, 2021 | 1.8% | +5.0 |
| FY2020 | Dec 31, 2020 | -3.2% | +2.4 |
| FY2019 | Dec 31, 2019 | -5.6% | +41.6 |
| FY2018 | Dec 31, 2018 | -47.2% | −22.1 |
| FY2017 | Dec 31, 2017 | -25.2% | +25.3 |
| FY2016 | Dec 31, 2016 | -50.4% | +69.7 |
| FY2015 | Dec 31, 2015 | -120.1% | +56.9 |
| FY2014 | Dec 31, 2014 | -177.0% | +514.0 |
| FY2013 | Dec 31, 2013 | -691.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -6.0% | +16.4 |
| Q2 FY2026 | Jun 30, 2026 | -28.5% | −6.5 |
| Q1 FY2026 | Mar 31, 2026 | -25.1% | +14.8 |
| Q4 FY2025 | Dec 31, 2025 | -12.9% | +71.4 |
| Q3 FY2025 | Sep 30, 2025 | -22.4% | +37.1 |
| Q2 FY2025 | Jun 30, 2025 | -22.0% | −21.2 |
| Q1 FY2025 | Mar 31, 2025 | -39.9% | −15.8 |
| Q4 FY2024 | Dec 31, 2024 | -84.3% | −77.8 |
| Q3 FY2024 | Sep 30, 2024 | -59.5% | −27.0 |
| Q2 FY2024 | Jun 30, 2024 | -0.8% | +29.1 |
| Q1 FY2024 | Mar 31, 2024 | -24.0% | −3.9 |
| Q4 FY2023 | Dec 31, 2023 | -6.5% | +4.1 |
| Q3 FY2023 | Sep 30, 2023 | -32.5% | −26.8 |
| Q2 FY2023 | Jun 30, 2023 | -29.9% | +36.6 |
| Q1 FY2023 | Mar 31, 2023 | -20.2% | +9.7 |
| Q4 FY2022 | Dec 31, 2022 | -10.6% | −21.8 |
| Q3 FY2022 | Sep 30, 2022 | -5.7% | +3.5 |
| Q2 FY2022 | Jun 30, 2022 | -66.5% | −72.2 |
| Q1 FY2022 | Mar 31, 2022 | -29.9% | −29.0 |
| Q4 FY2021 | Dec 31, 2021 | 11.2% | +6.9 |
| Q3 FY2021 | Sep 30, 2021 | -9.2% | −4.8 |
| Q2 FY2021 | Jun 30, 2021 | 5.7% | +2.6 |
| Q1 FY2021 | Mar 31, 2021 | -0.9% | +14.6 |
| Q4 FY2020 | Dec 31, 2020 | 4.3% | +0.4 |
| Q3 FY2020 | Sep 30, 2020 | -4.4% | −0.4 |
| Q2 FY2020 | Jun 30, 2020 | 3.1% | +5.6 |
| Q1 FY2020 | Mar 31, 2020 | -15.5% | +15.5 |
| Q4 FY2019 | Dec 31, 2019 | 3.8% | +44.9 |
| Q3 FY2019 | Sep 30, 2019 | -4.0% | +36.2 |
| Q2 FY2019 | Jun 30, 2019 | -2.5% | +58.9 |
| Q1 FY2019 | Mar 31, 2019 | -31.0% | +18.8 |
| Q4 FY2018 | Dec 31, 2018 | -41.1% | −27.8 |
| Q3 FY2018 | Sep 30, 2018 | -40.2% | −22.4 |
| Q2 FY2018 | Jun 30, 2018 | -61.4% | −36.2 |
| Q1 FY2018 | Mar 31, 2018 | -49.9% | +3.7 |
| Q4 FY2017 | Dec 31, 2017 | -13.3% | +20.0 |
| Q3 FY2017 | Sep 30, 2017 | -17.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -25.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -53.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -33.2% | – |
See a number that looks wrong?